Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 4Lung Neoplasms 3Breast Neoplasms 3Stomach Neoplasms 2Pain 2Lymphoma 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Rectal Neoplasms 1Postoperative Hemorrhage 1Polyposis, Gastric 1Oropharyngeal Neoplasms 1Nerve Block 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Musculoskeletal Diseases 1Multiple Myeloma 1Mouth Neoplasms 1Malignant Neoplasms of Male Genital Organs 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Hairy Cell 1Leukemia 1Leiomyoma 1Hypotension 1Hodgkin Disease 1

Interventions

parathyroid hormone-related peptide (1-36) 2Cholecalciferol 2upadacitinib 1guizhi-shaoyao-zhimu decoction 1Xylitol 1Sodium Chloride 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1Epinephrine 1Congresses as Topic 1Clonidine 1Bone Marrow Transplantation 1Adrenal Cortex Hormones 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Musculoskeletal Diseases × Epinephrine × Clear all
NCT05355597 2025-04-09

"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"

Atlantic Health System

Phase 2 Terminated
116 enrolled

Musculoskeletal Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡